http://www.renub.com/report/cancer-test-market-forecast-companies-cancer-test-platform-pipeline-analysis-and-clinical-trials---global-125

Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters.

A. Global – Cancer Testing Market and New Cases (Chapter 2)
B. Global – Cancer Testing Market Share & Forecast (Chapter 3)
C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4)
D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5)
E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6)
F. Geographic Region – Number of New Cancer Cases (Chapter 7)
G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8)

Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4)

• Prostate Specific Antigen (PSA) Test Market & Forecast
• Fecal Occult Blood Test Market & Forecast
• Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast
• Human Papilloma Virus (HPV) Test Market & Forecast
• Bladder Test Market & Forecast
• Serum Based Cancer Markers Market & Forecast
• Pharmacognostic Histology Market & Forecast
• Flow Cytometry Market & Forecast
• Other Test Market & Forecast

Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5)

• Bladder Cancer Test Market & Forecast
• Breast Cancer Test Market & Forecast
• Cervical Cancer Test Market & Forecast
• Colorectal (Colon) Cancer Test Market & Forecast
• Ovarian Cancer Test Market & Forecast
• Prostate Cancer Test Market & Forecast
• Liver Cancer Test Market & Forecast
• Flow Cytometry Market & Forecast
• Other Organ Specific Cancer Test Market & Forecast

Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6)

1 Abbott 11 Genomic Health Inc
2 Radient Pharmaceuticals 12 QIAGEN Marseille (Earlier Ipsogen)
3 BD Diagnostics 13 Myriad Genetics, Inc
4 Beckman Coulter, Inc. 14 Panacea Pharmaceuticals, Inc.
5 BioCurex 15 Qiagen
6 bioMerieux 16 Siemens Heathcare Diagnostics
7 Cepheid 17 Roche
8 CytoCore Inc. 18 Ventana Medical Systems
9 DiagnoCure, Inc 19 Trovagene Inc
10 Gen-Probe, Inc. 20 Vermillion, Inc


Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7)


1. Africa
2. Americas
3. Asia
4. Europe
5. Oceania


Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8)

1 Bladder Cancer 15 Myeloma
2 Brain Cancer 16 Nasopharynx
3 Breast Cancer 17 Non-Hodgkin Lymphoma
4 Cervix Cancer 18 Oesophagus
5 Colorectal Cancer 19 Oral Cavity
6 Corpus Cancer 20 Other Pharynx
7 Hodgkin’s Lymphoma 21 Ovary Cancer
8 Kaposi Sarcoma 22 Pancreas Cancer
9 Kidney Cancer 23 Prostate Cancer
10 Larynx Cancer 24 Stomach Cancer
11 Leukaemia 25 Testis Cancer
12 Liver Cancer 26 Thyroid Cancer
13 Lung Cancer 27 Other Sites
14 Melanoma

Cancer Site - Clinical Trials (Chapter 8)


1. Bladder Cancer
2. Cervical Cancer
3. Colorectal Cancer
4. Liver Cancer
5. Ovarian Cancer
6. Prostate Cancer

ontact Us

Andy Hill
Sr. Manager - Publisher Relation
Sales & Marketing Div
Renub Research
Email: [email protected]
Phone: +1-678-302-0700 (USA) +91-120-254-5750 (India)
Web: http://www.renub.com/